"Sigmodontinae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.
Descriptor ID |
D016205
|
MeSH Number(s) |
B01.050.150.900.649.313.992.635.075.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sigmodontinae".
Below are MeSH descriptors whose meaning is more specific than "Sigmodontinae".
This graph shows the total number of publications written about "Sigmodontinae" by people in this website by year, and whether "Sigmodontinae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
2003 | 1 | 2 | 3 |
2005 | 0 | 2 | 2 |
2006 | 0 | 1 | 1 |
2007 | 0 | 2 | 2 |
2008 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 1 | 2 | 3 |
2015 | 0 | 3 | 3 |
2016 | 0 | 2 | 2 |
2018 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sigmodontinae" by people in Profiles.
-
Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies. Nat Microbiol. 2024 Aug; 9(8):2128-2143.
-
In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections. Virology. 2023 09; 586:115-121.
-
Non-gradient and genotype-dependent patterns of RSV gene expression. PLoS One. 2020; 15(1):e0227558.
-
Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge. Vaccine. 2018 12 18; 36(52):8069-8078.
-
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Nat Commun. 2016 12 21; 7:13916.
-
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. J Virol. 2016 08 15; 90(16):7508-7518.
-
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2016 01; 60(1):6-13.
-
Mesoamerican nephropathy: a neglected tropical disease with an infectious etiology? Microbes Infect. 2015 Oct; 17(10):671-5.
-
Benzimidazole analogs inhibit respiratory syncytial virus G protein function. Antiviral Res. 2015 Sep; 121:31-8.
-
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein. EMBO Mol Med. 2014 Nov; 6(11):1436-54.